• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall MAGNIVISION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall MAGNIVISION see related information
Date Initiated by Firm May 02, 2003
Date Posted February 24, 2004
Recall Status1 Terminated 3 on July 07, 2012
Recall Number Z-0541-04
Recall Event ID 26331
Product Classification Frame, Spectacle - Product Code HQZ
Product Product is Magnivision UltraLights reading glasses which have the dioptic power on the label and ''MAGNIVISION AN AMERICAN GREETINGS COMPANY Miramar, FL 33025''
Code Information Product is not coded.
Recalling Firm/
Manufacturer
Magnivision, Inc.
3700 Commerce Pkwy.
Miramar FL 33025
For Additional Information Contact Eleanor Chilson
954-986-9000 Ext. 3413
Manufacturer Reason
for Recall
Possibility of eye injury from large temple tags on promotional sale product when customer tries them on in store.
FDA Determined
Cause 2
Other
Action The firm sent an e-mail dated 4/16/03 to their only direct wholesaler telling them to hold the product and followed up with a phone call infomring them of the retagging on 5/2/03 and a sufficient quantify of tags to relabel product at the retail level. Also they visited the wholesaler and retagged in house stock with the smaller tag.
Quantity in Commerce 145884
Distribution Product was distributed to a a wholesaler in Florida.
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-